Sign in
4

Changes in Ownership

C4 Therapeutics, Inc. Filed Acc 0001662579-23-000099

Options or other derivatives

  • Chief Business Officer acquired 120,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Boyle Scott N · Chief Business Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-09-18 Grant or award : show line 1 in the form Stock Option (Right to Buy) +120,000 120,000 D
Loading xslF345X05/wk-form4_1695165770.xml…